4 results on '"Bezzerri, Valentino"'
Search Results
2. Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function
- Author
-
Tamanini, Anna, primary, Borgatti, Monica, additional, Finotti, Alessia, additional, Piccagli, Laura, additional, Bezzerri, Valentino, additional, Favia, Maria, additional, Guerra, Lorenzo, additional, Lampronti, Ilaria, additional, Bianchi, Nicoletta, additional, Dall'Acqua, Francesco, additional, Vedaldi, Daniela, additional, Salvador, Alessia, additional, Fabbri, Enrica, additional, Mancini, Irene, additional, Nicolis, Elena, additional, Casavola, Valeria, additional, Cabrini, Giulio, additional, and Gambari, Roberto, additional
- Published
- 2011
- Full Text
- View/download PDF
3. Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells.
- Author
-
Favia M, Mancini MT, Bezzerri V, Guerra L, Laselva O, Abbattiscianni AC, Debellis L, Reshkin SJ, Gambari R, Cabrini G, and Casavola V
- Subjects
- Animals, Cell Line, Cell Membrane genetics, Cell Membrane metabolism, Cyclic AMP-Dependent Protein Kinases metabolism, Cystic Fibrosis genetics, Cystic Fibrosis pathology, Endoplasmic Reticulum metabolism, Furocoumarins therapeutic use, HEK293 Cells, Humans, Lung pathology, Protein Transport genetics, Rats, Chlorides metabolism, Cystic Fibrosis drug therapy, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Furocoumarins pharmacology
- Abstract
Cystic fibrosis transmembrane conductance regulator (CFTR) carrying the F508del mutation is retained in endoplasmic reticulum and fails to traffic to the cell surface where it functions as a protein kinase A (PKA)-activated chloride channel. Pharmacological correctors that rescue the trafficking of F508del CFTR may overcome this defect; however, the rescued F508del CFTR still displays reduced chloride permeability. Therefore, a combined administration of correctors and potentiators of the gating defect is ideal. We recently found that 4,6,4'-trimethylangelicin (TMA), besides inhibiting the expression of the IL-8 gene in airway cells in which the inflammatory response was challenged with Pseudomonas aeruginosa, also potentiates the cAMP/PKA-dependent activation of wild-type CFTR or F508del CFTR that has been restored to the plasma membrane. Here, we demonstrate that long preincubation with nanomolar concentrations of TMA is able to effectively rescue both F508del CFTR-dependent chloride secretion and F508del CFTR cell surface expression in both primary or secondary airway cell monolayers homozygous for F508del mutation. The correction effect of TMA seems to be selective for CFTR and persisted for 24 h after washout. Altogether, the results suggest that TMA, besides its anti-inflammatory and potentiator activities, also displays corrector properties., (Copyright © 2014 the American Physiological Society.)
- Published
- 2014
- Full Text
- View/download PDF
4. Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function.
- Author
-
Tamanini A, Borgatti M, Finotti A, Piccagli L, Bezzerri V, Favia M, Guerra L, Lampronti I, Bianchi N, Dall'Acqua F, Vedaldi D, Salvador A, Fabbri E, Mancini I, Nicolis E, Casavola V, Cabrini G, and Gambari R
- Subjects
- Bronchi cytology, Cell Line, Chlorides metabolism, Dose-Response Relationship, Drug, Epithelial Cells drug effects, Epithelial Cells metabolism, Furocoumarins chemistry, Gene Expression Regulation drug effects, Humans, Interleukin-8 metabolism, NF-kappa B metabolism, Phosphoproteins metabolism, Phosphorylation drug effects, Promoter Regions, Genetic genetics, Protein Binding drug effects, Pseudomonas aeruginosa drug effects, RNA, Messenger genetics, RNA, Messenger metabolism, Trioxsalen chemistry, Trioxsalen pharmacology, Cystic Fibrosis Transmembrane Conductance Regulator metabolism, Furocoumarins pharmacology, Interleukin-8 genetics, Transcription, Genetic drug effects
- Abstract
Chronic inflammatory response in the airway tract of patients affected by cystic fibrosis is characterized by an excessive recruitment of neutrophils to the bronchial lumina, driven by the chemokine interleukin (IL)-8. We previously found that 5-methoxypsoralen reduces Pseudomonas aeruginosa-dependent IL-8 transcription in bronchial epithelial cell lines, with an IC(50) of 10 μM (Nicolis E, Lampronti I, Dechecchi MC, Borgatti M, Tamanini A, Bezzerri V, Bianchi N, Mazzon M, Mancini I, Giri MG, Rizzotti P, Gambari R, Cabrini G. Int Immunopharmacol 9: 1411-1422, 2009). Here, we extended the investigation to analogs of 5-methoxypsoralen, and we found that the most potent effect is obtained with 4,6,4'-trimethylangelicin (TMA), which inhibits P. aeruginosa-dependent IL-8 transcription at nanomolar concentration in IB3-1, CuFi-1, CFBE41o-, and Calu-3 bronchial epithelial cell lines. Analysis of phosphoproteins involved in proinflammatory transmembrane signaling evidenced that TMA reduces the phosphorylation of ribosomal S6 kinase-1 and AKT2/3, which we found indeed involved in P. aeruginosa-dependent activation of IL-8 gene transcription by testing the effect of pharmacological inhibitors. In addition, we found a docking site of TMA into NF-κB by in silico analysis, whereas inhibition of the NF-κB/DNA interactions in vitro by EMSA was observed at high concentrations (10 mM TMA). To further understand whether NF-κB pathway should be considered a target of TMA, chromatin immunoprecipitation was performed, and we observed that TMA (100 nM) preincubated in whole living cells reduced the interaction of NF-κB with the promoter of IL-8 gene. These results suggest that TMA could inhibit IL-8 gene transcription mainly by intervening on driving the recruitment of activated transcription factors on IL-8 gene promoter, as demonstrated here for NF-κB. Although the complete understanding of the mechanism of action of TMA deserves further investigation, an activity of TMA on phosphorylating pathways was already demonstrated by our study. Finally, since psoralens have been shown to potentiate cystic fibrosis transmembrane conductance regulator (CFTR)-mediated chloride transport, TMA was tested and found to potentiate CFTR-dependent chloride efflux. In conclusion, TMA is a dual-acting compound reducing excessive IL-8 expression and potentiating CFTR function.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.